share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股sec公告 ·  05/22 16:15
Moomoo AI 已提取核心信息
Applied UV, Inc. has received a notification from the Nasdaq Listing Qualifications Staff on May 16, 2024, indicating that the company's common stock did not meet the minimum closing bid price of $1.00 per share over a 31 consecutive business day period from April 3, 2024, to May 15, 2024. This requirement is a condition for continued listing on The Nasdaq Capital Market under the Nasdaq Listing Rule 5550(a)(2). The company has been granted an initial 180-day compliance period, ending on November 12, 2024, to address and rectify the bid price deficiency. If Applied UV fails to regain compliance within this timeframe, it may be eligible for an additional 180-day period, provided it meets certain conditions, including the possibility of a reverse stock split. Failure to comply within the...Show More
Applied UV, Inc. has received a notification from the Nasdaq Listing Qualifications Staff on May 16, 2024, indicating that the company's common stock did not meet the minimum closing bid price of $1.00 per share over a 31 consecutive business day period from April 3, 2024, to May 15, 2024. This requirement is a condition for continued listing on The Nasdaq Capital Market under the Nasdaq Listing Rule 5550(a)(2). The company has been granted an initial 180-day compliance period, ending on November 12, 2024, to address and rectify the bid price deficiency. If Applied UV fails to regain compliance within this timeframe, it may be eligible for an additional 180-day period, provided it meets certain conditions, including the possibility of a reverse stock split. Failure to comply within the granted periods could lead to the delisting of the company's common stock from The Nasdaq Capital Market. However, the notice does not immediately affect the listing of Applied UV's common stock, which will continue to trade under the symbol 'AUVI'. The company is currently exploring options to regain compliance, but there is no certainty that it will achieve this or maintain other Nasdaq listing requirements. The report was signed by Mike Riccio, Chief Financial Officer of Applied UV, Inc., on May 22, 2024.
Applied UV, Inc.已于2024年5月16日收到纳斯达克上市资格工作人员的通知,表明该公司的普通股在2024年4月3日至2024年5月15日的连续31个工作日内未达到每股1.00美元的最低收盘价。该要求是根据纳斯达克上市规则5550(a)(2)继续在纳斯达克资本市场上市的条件。该公司已获准最初的180天合规期,该合规期将于2024年11月12日结束,以解决和纠正投标价格缺陷。如果Applied UV未能在这段时间内恢复合规性,则可能有资格再延长180天,前提是它满足某些条件,包括反向股票拆分的可能性。未能在授权期限内遵守规定可能会导致该公司的普通股从纳斯达克资本市场退市。但是,该通...展开全部
Applied UV, Inc.已于2024年5月16日收到纳斯达克上市资格工作人员的通知,表明该公司的普通股在2024年4月3日至2024年5月15日的连续31个工作日内未达到每股1.00美元的最低收盘价。该要求是根据纳斯达克上市规则5550(a)(2)继续在纳斯达克资本市场上市的条件。该公司已获准最初的180天合规期,该合规期将于2024年11月12日结束,以解决和纠正投标价格缺陷。如果Applied UV未能在这段时间内恢复合规性,则可能有资格再延长180天,前提是它满足某些条件,包括反向股票拆分的可能性。未能在授权期限内遵守规定可能会导致该公司的普通股从纳斯达克资本市场退市。但是,该通知并未立即影响Applied UV普通股的上市,该普通股将继续以'AUVI'的代码进行交易。该公司目前正在探索恢复合规性的备选方案,但尚不确定是否会实现这一目标或维持其他纳斯达克上市要求。该报告由应用紫外光公司首席财务官迈克·里西奥于2024年5月22日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息